Moderna is suing Pfizer and BioNTech, accusing the companies of infringing on Moderna’s patents when they partnered to develop their own COVID-19 vaccine. Moderna is suing Pfizer and BioNTech ...

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The validity of the patent is at the heart of patent litigation between CureVac and fellow German biotech BioNTech and its partner Pfizer, claiming infringement by their Comirnaty coronavirus shot.

Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. *Data is provided by Barchart.com. Data reflects weightings calculated ...

Invest in the best value stocks with Interactive Brokers for quick trade execution. Value stocks/companies consist of companies whose current valuation appears low relative to their fundamentals ...

The U.S. currently uses five COVID-19 vaccines from Pfizer, Moderna, and Novavax. All are safe and effective against the coronavirus, especially in preventing hospitalization and death. The ...

At about the same time, Pfizer and BioNTech spoke with Graham about using the 2P mutation in their vaccine. Because their work was patented and widely published, other drugmakers—including ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our ...